THERMOGENESIS CORP. Receives $540,000 Order for Seven Ultra Rapid Plasma Freezers From Aventis Bio-Services, Inc.
RANCHO CORDOVA, Calif.--(BW HealthWire)--Aug. 28, 2000-- THERMOGENESIS CORP. (Nasdaq:KOOL - news) announced that Aventis Bio-Services, Inc. (formerly Centeon Bio-Services, Inc.) placed an order for seven MP2000 Plasma Freezers which freeze one-litre bottles of plasma five times faster than conventional air blast freezers. Rapidly frozen plasma retains higher levels of the Factor VIII protein used for the treatment of hemophilia. The $540,000 order includes the seven freezers, service contract and other accessories, which will be installed in seven of the 47 plasma collection centers recently acquired by Aventis from Seramed. THERMOGENESIS CORP. anticipates shipping all seven MP2000 Freezers by the end of the calendar year.
THERMOGENESIS CORP. anticipates additional MP2000 Freezers will be installed in the remaining 40 newly acquired plasma collection centers in order to standardize the production process with the existing Aventis plasma collection centers. Aventis has purchased 86 of the Ultra Rapid Freezers for 43 of their plasma collection centers.
Dr. James Godsey, president and COO of THERMOGENESIS CORP. commented, ``... we were pleased to see Aventis continue their practice of exclusively using only THERMOGENESIS CORP.'s Ultra Rapid Plasma Freezers in their source plasma collection facilities and that the use continues to grow as their network of plasma centers grows through acquisition of existing centers. Aventis is the global leader in the production of the highest quality plasma proteins.''
About Aventis Bio-Services, Inc.
Aventis Bio-Services, Inc. is a wholly owned subsidiary of Aventis, the joint venture combining the plasma operations of Rhone-Poulenc Rorer and Hoechst AG, and is the world's largest fully integrated plasma collection company. Aventis is the global leader in the plasma protein industry, producing a comprehensive line of therapies that include coagulation therapies for the treatment of hemophilia, immunoglobulins for the prevention and treatment of immune disorders, and plasma expanders for the treatment of a variety of conditions such as shock, burns and circulatory disorders.
About THERMOGENESIS CORP.
THERMOGENESIS CORP. has been a pioneer in designing, manufacturing and distributing equipment to collect, cryopreserve and archive highly sensitive blood products and biological tissue for more than 10 years.
The statements contained in this release which are not historical facts are forward-looking statements that are subject to risks and uncertainties that could cause actual results to differ materially from those expressed in the forward-looking statements, including, but not limited to, certain delays beyond the company's control with respect to market acceptance of new technologies and products, delays in testing and evaluation of products, and other risks detailed from time to time in the company's filings with the Securities and Exchange Commission.
Email this story - |
